Medicines Optimisation
Hello reader.

Everybody Dance Now - Moving Medicine

Everybody Dance Now - Moving Medicine
"Moving Medicine is the single most important advance in therapeutics in my 50 years in medicine. The benefit to harm ratio is outstandingly favourable and every drug or psychological prescription for a long-term condition should be partnered by a Moving Medicine prescription of activity."  Sir Muir Gray Kt CBE DSc MD

Read more

Wet Age-Related Macular Degeneration - Treatment Options

The CCGs in North Cumbria and the North East have commissioned this short film to help patients understand their options for treatment of wet age-related macular degeneration - and to support shared decision-making. https://youtu.be/vKX65U2sfo0

Read more

Influenza - Antiviral Prescribing Guidance

Public Health England have published udated guidance on how to manage suspected or confirmed 'flu using antiviral agents. - with a new frequently asked questions section. The guidance covers: definitions treatment of suspected or confirmed influenza post-exposure prophylaxis supply of zanamivir acqueous solution use of anti-virals in pregnancy, breastfeeding, hepatic or renal dysfunction

Read more

Antimicrobial Prescribing Guidance - NICE & PHE Update

Primary care guidance on management of common infections produced by Public Health England (PHE) has been used as the core source document for regional antimicrobial prescribing  guidelines for many years. NICE have been producing complementary antimicrobial prescribing guidelines for just over a year - with two-page visual summaries available for: sinusitis; sore throat; otitis media; prostatitis; lower UTI; pyelonephritis and …

Read more

Medicinal Cannabis - Limits on Prescribing

The Chief Medical Officer, National Medical Director and Chief Pharmaceutical Officer have written to GPs to explain changes to regulations covering medicinal use of cannabis-based products - and the anticipated effects on prescribing practice. Prescribers may find the following extracts from the letter helpful: Due to the limited evidence base and their unlicensed nature, the Government has chosen to restrict …

Read more

Self-Monitoring of Blood Glucose in Type 2 Diabetes - little if any benefit for most

The NHS National Institute for Health Research has published a SIGNAL article highlighting a systematic review of 24 studies (including 5,454 people) investigating the value of self-monitoring of blood glucose by people with type 2 diabetes who are not treated with insulin. The NIHR SIGNAL concludes that "patients with type 2 diabetes who monitor their blood glucose themselves may see small, …

Read more

Bath Additives for Children with Eczema - No Benefit

A large (n = 482) well-conducted trial based in UK primary care has found "no evidence of clinical benefit of including emollient bath additives in the standard management of childhood eczema." Details of the trial - funded by the NHS National Institute for Health Research - can be found here. Over the last 12 months, CCGs in Cumbria, the North …

Read more

Gabapentin & Pregabalin - to be Controlled Drugs in 2019

The Home Office has announced plans to classify both gabapentin and pregabalin as Class C controlled drugs in April 2019. The decision to apply Misuse of Drugs act controls to gabapentin and pregabalin is based on advice from the Advisory Council on the Misuse of Drugs - in response to concerns over medicinal misuse, illegal diversion of the drugs and addiction - …

Read more

NHS England Press Release - Adalimumab Patent Expiry

NHS England have issued a Press Release announcing that the NHS is set "to save £150 million by switching to new versions of most costly drug." NHS Hospitals have been asked "to ensure they are ready to realise savings of up to £150 million a year to reinvest in frontline care after the patent on the NHS’s most costly drug ends …

Read more

Prevention of Future Deaths Report - Adrenaline Auto-Injectors

A recent post noted that HM Assistant Coroner for West London intended to issue a Regulation 28 Prevention of Future Deaths Report to the MHRA raising concerns about the adrenaline auto-injectors used by Natasha Ednan-Laperouse - in particular whether the length of the needle and the dose administered were appropriate. The Coroner's report has new been posted on the Judiciary …

Read more
twitter
MailPoet